These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27822071)

  • 1. Biosimilar epoetin for the management of chemotherapy-induced anemia in elderly patients.
    Kurtz JE; Soubeyran P; Michallet M; Luporsi E; Albrand H
    Onco Targets Ther; 2016; 9():6689-6693. PubMed ID: 27822071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BiOsimilaRs in the management of anaemia secondary to chemotherapy in HaEmatology and Oncology: results of the ORHEO observational study.
    Michallet M; Luporsi E; Soubeyran P; Amar NA; Boulanger V; Carreiro M; Dourthe LM; Labourey JL; Lepille D; Maloisel F; Mouysset JL; Nahon S; Narciso B; Nouyrigat P; Radji R; Sakek N; Albrand H;
    BMC Cancer; 2014 Jul; 14():503. PubMed ID: 25011615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosimilar Retacrit
    Losem C; Koenigsmann M; Rudolph C
    Onco Targets Ther; 2017; 10():1295-1305. PubMed ID: 28280364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retacrit®, Biosimilar of Epoetin Alfa, in Chemotherapy-Induced Anemia in Routine Practice: Impact of Iron Supplementation.
    Laribi K; Spaeth D; Scotte F; Ray-Coquard I
    Oncology; 2022; 100(10):519-528. PubMed ID: 35051930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of biosimilar epoetin alpha in patients with chronic lymphoid neoplasms and chemotherapy-induced anaemia: An observational, retrospective, monocentric analysis.
    Broccoli A; Argnani L; Stefoni V; Gandolfi L; Zinzani PL
    Hematol Oncol; 2018 Feb; 36(1):136-143. PubMed ID: 28332724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective open-label uncontrolled study of Epoetin zeta on the treatment of chemotherapy-induced anemia in solid tumors.
    Alifieris CE; Orfanakos K; Papanota A; Stathopoulos GP; Sitaras N; Trafalis DT
    J Cancer Res Clin Oncol; 2017 Apr; 143(4):717-725. PubMed ID: 28078434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of erythropoiesis-stimulating agents among chemotherapy patients with hemoglobin exceeding 12 grams per deciliter.
    Nordstrom BL; Luo W; Fraeman K; Whyte JL; Nordyke RJ
    J Manag Care Pharm; 2008; 14(9):858-69. PubMed ID: 19006442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Comparison of Renogen, a Biosimilar Epoetin-a, with the Originator, Eprex, in Chronic Kidney Disease Anemia in Indonesia: A Preliminary Study.
    Hustrini NM; Siregar P; Setiawati A; Nugroho P
    Acta Med Indones; 2019 Jul; 51(3):230-237. PubMed ID: 31699946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of anaemia in oncohaematological patients treated with biosimilar epoetin alfa: results of an Italian observational, retrospective study.
    Rosti G; Petrini M; Bosi A; Galieni P; Bernardi D; Giglio G; Dorotea L; Falini B; Scelzi E; Veltri E; Castelli R; Longagnani C; Raggi T; Simonetti F
    Ther Adv Med Oncol; 2017 Jan; 9(1):22-32. PubMed ID: 28203295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of biosimilar epoetin to increase hemoglobin levels in patients with chemotherapy-induced anemia: real-life clinical experience.
    Kerkhofs L; Boschetti G; Lugini A; Stanculeanu DL; Palomo AG
    Future Oncol; 2012 Jun; 8(6):751-6. PubMed ID: 22443466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoglobin response and influence on left ventricular hypertrophy after 24-week treatment of a biosimilar epoetin-alfa in hemodialysis patients with anemia.
    Thanakitcharu P; Siriwiwatanakul N
    J Med Assoc Thai; 2007 Dec; 90(12):2574-86. PubMed ID: 18386706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weekly epoetin alfa during adjuvant chemotherapy for breast cancer: effect on hemoglobin levels and quality of life.
    Hudis CA; Vogel CL; Gralow JR; Williams D;
    Clin Breast Cancer; 2005 Jun; 6(2):132-42. PubMed ID: 16001991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
    Voravud N; Sriuranpong V
    J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An induction dose of epoetin alpha of 40 000 IU daily for three consecutive days increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy.
    Mustacchi G; Ceccherini R; Dellach C; Foladore S; Milani S; Leita M; Sisto M
    Ann Oncol; 2006 Nov; 17(11):1705-8. PubMed ID: 16980603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label, randomized, multicenter, controlled study of epoetin alfa for the treatment of anemia of chronic kidney disease in the long term care setting.
    Patel M; Thimons DG; Winston JL; Langholff W; McGowan T
    J Am Med Dir Assoc; 2012 Mar; 13(3):244-8. PubMed ID: 21450214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of an induction therapy with epoetin alfa in anemic cancer patients receiving concomitant chemotherapy.
    Cortesi E; Mancuso A; De Pasquale Ceratti A; Pizzardi N; D'Auria G; Accettura C; Beccaglia P; Bertelletti D; De Marinis F
    Oncologist; 2004; 9(4):459-68. PubMed ID: 15266099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: an open-label, non randomized, pilot study.
    Santini D; Vincenzi B; La Cesa A; Virzi V; Navajas F; Malafarina V; Dicuonzo G; Cassandro R; Esposito V; Montesarchio V; Groeger AM; Tonini G
    Anticancer Res; 2005; 25(1B):669-74. PubMed ID: 15816644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosimilar epoetin α is as effective as originator epoetin-α plus liposomal iron (Sideral®), vitamin B12 and folates in patients with refractory anemia: A retrospective real-life approach.
    Giordano G; Mondello P; Tambaro R; Perrotta N; D'Amico F; D'Aveta A; Berardi G; Carabellese B; Patriarca A; Corbi GM; DI Marzio L; Licianci A; Berardi D; DI Lullo L; DI Marco R
    Mol Clin Oncol; 2015 Jul; 3(4):781-784. PubMed ID: 26171179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epoetin alfa 60,000 U once weekly followed by 120,000 U every 3 weeks increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy.
    Patton J; Kuzur M; Liggett W; Miranda F; Varsos H; Porter L
    Oncologist; 2004; 9(1):90-6. PubMed ID: 14755018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective multicenter study of HX575 (biosimilar epoetin-α) in patients with chronic kidney disease applying a target hemoglobin of 10--12 g/dl.
    Hörl WH; Locatelli F; Haag-Weber M; Ode M; Roth K;
    Clin Nephrol; 2012 Jul; 78(1):24-32. PubMed ID: 22732334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.